首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Local recurrence of stage 1 and 2 breast cancer after skin-sparing mastectomy and immediate breast reconstruction in a 15-year series.
【24h】

Local recurrence of stage 1 and 2 breast cancer after skin-sparing mastectomy and immediate breast reconstruction in a 15-year series.

机译:保留皮肤的乳房切除术和即刻乳房重建后的15年系列中的1和2期乳腺癌的局部复发。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIMS: Since the introduction of skin-sparing mastectomy (SSM) in 1991 concerns on local control and recurrence rates have been discussed in the literature. The aim of this study is to examine in particular incidence of local recurrence in a 15-year consecutive series of breast cancer patients having undergone SSM and immediate breast reconstruction (IBR) at a single population-based institution. METHODS: One hundred and forty-six consecutive patients with either stage 1 or 2 breast cancer who underwent SSM followed by IBR from 1992 to 2006 were included in this study. A retrospective review of patient records was conducted. RESULTS: During a mean follow-up time of 51 months, four local recurrences of the native breast skin were accounted for. In addition, three regional lymph node recurrences and four systemic recurrences took place. All of the local and regional recurrences were handled by salvage surgery followed by adjuvant oncological therapies. During a mean follow-up of 35 months after the detection and treatment of the locoregional recurrences none of the patients developed new recurrences. CONCLUSIONS: Our present study concludes that SSM followed by IBR seems oncologically sound procedure for stage 1 and 2 breast cancer patients. In addition, local recurrences and regional lymph node recurrences are not always associated with systemic relapse.
机译:目的:自1991年采用保留皮肤的乳房切除术(SSM)以来,有关局部控制和复发率的问题已在文献中进行了讨论。这项研究的目的是特别检查连续15年在单一人群机构中接受SSM和即刻乳房重建(IBR)的一系列乳腺癌患者的局部复发率。方法:从1992年至2006年,共146例行SSM继之IBR的1或2期乳腺癌患者。对患者记录进行回顾性审查。结果:在平均5​​1个月的随访期间,共计有4次局部乳腺皮肤局部复发。此外,发生了三个区域性淋巴结复发和四个全身性复发。所有局部和区域性复发均通过抢救手术后再行辅助肿瘤治疗来解决。在局部复发的检测和治疗后的35个月的平均随访中,没有一例患者出现新的复发。结论:我们目前的研究得出结论,对于1期和2期乳腺癌患者,SSM联合IBR似乎在肿瘤学上是合理的。此外,局部复发和区域淋巴结复发并不总是与全身性复发相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号